{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:10:44Z","timestamp":1785798644480,"version":"3.56.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:00:00Z","timestamp":1615420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:00:00Z","timestamp":1615420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"NIH National Cancer Institute","doi-asserted-by":"crossref","award":["U54CA156735"],"award-info":[{"award-number":["U54CA156735"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000054","name":"NIH National Cancer Institute","doi-asserted-by":"crossref","award":["U54CA156735"],"award-info":[{"award-number":["U54CA156735"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000054","name":"NIH National Cancer Institute","doi-asserted-by":"crossref","award":["U54CA156735"],"award-info":[{"award-number":["U54CA156735"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]},{"name":"University of North Carolina System"},{"name":"NIH  National Institute on Minority Health and Health Disparities","award":["U54MD012392"],"award-info":[{"award-number":["U54MD012392"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Personalized medicine holds tremendous promise for improving safety and efficacy of drug therapies by optimizing treatment regimens. Rapidly developed patient-derived xenografts (pdx) could be a helpful tool for analyzing the effect of drugs against an individual\u2019s tumor by growing the tumor in an immunodeficient animal. Severe combined immunodeficiency (SCID) mice enable efficient in vivo expansion of vital tumor cells and generation of personalized xenografts. However, they are not amenable to large-scale rapid screening, which is critical in identifying new compounds from large compound libraries. The development of a zebrafish model suitable for pdx could facilitate large-scale screening of drugs targeted against specific malignancies. Here, we describe a novel strategy for establishing a zebrafish model for drug testing in leukemia xenografts. We used chronic myelogenous leukemia and acute myeloid leukemia for xenotransplantation into SCID zebrafish to evaluate drug screening protocols. We showed the in vivo efficacy of the ABL inhibitor imatinib, MEK inhibitor U0126, cytarabine, azacitidine and arsenic trioxide. We performed corresponding in vitro studies, demonstrating that combination of MEK- and FLT3-inhibitors exhibit an enhanced effect in vitro. We further evaluated the feasibility of zebrafish for transplantation of primary human hematopoietic cells that can survive at 15\u00a0day-post-fertilization. Our results provide critical insights to guide development of high-throughput platforms for evaluating leukemia.<\/jats:p>","DOI":"10.1038\/s41598-021-85141-5","type":"journal-article","created":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T11:03:49Z","timestamp":1615460629000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Targeted therapy of human leukemia xenografts in immunodeficient zebrafish"],"prefix":"10.1038","volume":"11","author":[{"given":"Ranganatha R.","family":"Somasagara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamil","family":"Haider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan S.","family":"Serody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Armistead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TinChung","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,11]]},"reference":[{"key":"85141_CR1","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1084\/jem.20160378","volume":"213","author":"JC Moore","year":"2016","unstructured":"Moore, J. C. et al. Single-cell imaging of normal and malignant cell engraftment into optically clear prkdc-null SCID zebrafish. J. Exp. Med. 213, 2575\u20132589. https:\/\/doi.org\/10.1084\/jem.20160378 (2016).","journal-title":"J. Exp. Med."},{"key":"85141_CR2","doi-asserted-by":"publisher","first-page":"6048","DOI":"10.1158\/0008-5472.CAN-18-1029","volume":"78","author":"P Letrado","year":"2018","unstructured":"Letrado, P., de Miguel, I., Lamberto, I., Diez-Martinez, R. & Oyarzabal, J. Zebrafish: Speeding up the cancer drug discovery process. Can. Res. 78, 6048\u20136058. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-1029 (2018).","journal-title":"Can. Res."},{"key":"85141_CR3","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature08761","volume":"464","author":"K Kissa","year":"2010","unstructured":"Kissa, K. & Herbomel, P. Blood stem cells emerge from aortic endothelium by a novel type of cell transition. Nature 464, 112\u2013115 (2010).","journal-title":"Nature"},{"key":"85141_CR4","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1182\/blood-2007-07-099499","volume":"111","author":"K Kissa","year":"2008","unstructured":"Kissa, K. et al. Live imaging of emerging hematopoietic stem cells and early thymus colonization. Blood 111, 1147\u20131156 (2008).","journal-title":"Blood"},{"key":"85141_CR5","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08738","volume":"464","author":"JY Bertrand","year":"2010","unstructured":"Bertrand, J. Y. et al. Haematopoietic stem cells derive directly from aortic endothelium during development. Nature 464, 108\u2013111 (2010).","journal-title":"Nature"},{"key":"85141_CR6","doi-asserted-by":"publisher","first-page":"e39327","DOI":"10.1371\/journal.pone.0039327","volume":"7","author":"KF Ferri-Lagneau","year":"2012","unstructured":"Ferri-Lagneau, K. F. et al. Ginger stimulates hematopoiesis via Bmp pathway in zebrafish. PLoS ONE 7, e39327. https:\/\/doi.org\/10.1371\/journal.pone.0039327 (2012).","journal-title":"PLoS ONE"},{"key":"85141_CR7","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41598-018-36338-8","volume":"9","author":"KF Ferri-Lagneau","year":"2019","unstructured":"Ferri-Lagneau, K. F., Haider, J., Sang, S. & Leung, T. Rescue of hematopoietic stem\/progenitor cells formation in plcg1 zebrafish mutant. Sci. Rep. 9, 244. https:\/\/doi.org\/10.1038\/s41598-018-36338-8 (2019).","journal-title":"Sci. Rep."},{"key":"85141_CR8","doi-asserted-by":"publisher","first-page":"5353","DOI":"10.1021\/jf401501s","volume":"61","author":"H Chen","year":"2013","unstructured":"Chen, H. et al. [10]-Gingerdiols as the major metabolites of [10]-gingerol in zebrafish embryos and in humans and their hematopoietic effects in zebrafish embryos. J. Agric. Food Chem. 61, 5353\u20135360. https:\/\/doi.org\/10.1021\/jf401501s (2013).","journal-title":"J. Agric. Food Chem."},{"key":"85141_CR9","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0070-2153(03)53004-6","volume":"53","author":"JL Galloway","year":"2003","unstructured":"Galloway, J. L. & Zon, L. I. Ontogeny of hematopoiesis: examining the emergence of hematopoietic cells in the vertebrate embryo. Curr. Top. Dev. Biol. 53, 139\u2013158 (2003).","journal-title":"Curr. Top. Dev. Biol."},{"key":"85141_CR10","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S0268-960X(98)90022-4","volume":"12","author":"J Palis","year":"1998","unstructured":"Palis, J. & Segel, G. B. Developmental biology of erythropoiesis. Blood Rev. 12, 106\u2013114 (1998).","journal-title":"Blood Rev."},{"key":"85141_CR11","doi-asserted-by":"publisher","first-page":"4102","DOI":"10.3390\/cancers3044102","volume":"3","author":"KS Moshal","year":"2011","unstructured":"Moshal, K. S., Ferri-Lagneau, K. F., Haider, J., Pardhanani, P. & Leung, T. Discriminating different cancer cells using a zebrafish in vivo assay. Cancers 3, 4102\u20134113. https:\/\/doi.org\/10.3390\/cancers3044102 (2011).","journal-title":"Cancers"},{"key":"85141_CR12","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.tcm.2010.10.001","volume":"20","author":"KS Moshal","year":"2010","unstructured":"Moshal, K. S., Ferri-Lagneau, K. F. & Leung, T. Zebrafish model: Worth considering in defining tumor angiogenesis. Trends Cardiovasc. Med. 20, 114\u2013119. https:\/\/doi.org\/10.1016\/j.tcm.2010.10.001 (2010).","journal-title":"Trends Cardiovasc. Med."},{"key":"85141_CR13","doi-asserted-by":"publisher","first-page":"5608","DOI":"10.1038\/onc.2015.516","volume":"35","author":"R Zhou","year":"2016","unstructured":"Zhou, R. et al. A novel association of neuropilin-1 and MUC1 in pancreatic ductal adenocarcinoma: Role in induction of VEGF signaling and angiogenesis. Oncogene 35, 5608\u20135618. https:\/\/doi.org\/10.1038\/onc.2015.516 (2016).","journal-title":"Oncogene"},{"key":"85141_CR14","doi-asserted-by":"publisher","first-page":"17406","DOI":"10.1073\/pnas.0703446104","volume":"104","author":"K Stoletov","year":"2007","unstructured":"Stoletov, K., Montel, V., Lester, R. D., Gonias, S. L. & Klemke, R. High-resolution imaging of the dynamic tumor cell vascular interface in transparent zebrafish. Proc. Natl. Acad. Sci. U.S.A. 104, 17406\u201317411. https:\/\/doi.org\/10.1073\/pnas.0703446104 (2007).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"85141_CR15","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1158\/0008-5472.CAN-06-4268","volume":"67","author":"S Nicoli","year":"2007","unstructured":"Nicoli, S., Ribatti, D., Cotelli, F. & Presta, M. Mammalian tumor xenografts induce neovascularization in zebrafish embryos. Can. Res. 67, 2927\u20132931. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-4268 (2007).","journal-title":"Can. Res."},{"key":"85141_CR16","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/bs.mcb.2016.10.009","volume":"138","author":"L Chen","year":"2017","unstructured":"Chen, L. et al. A zebrafish xenograft model for studying human cancer stem cells in distant metastasis and therapy response. Methods Cell Biol. 138, 471\u2013496. https:\/\/doi.org\/10.1016\/bs.mcb.2016.10.009 (2017).","journal-title":"Methods Cell Biol."},{"key":"85141_CR17","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1111\/j.1365-2141.2011.08661.x","volume":"153","author":"DP Corkery","year":"2011","unstructured":"Corkery, D. P., Dellaire, G. & Berman, J. N. Leukaemia xenotransplantation in zebrafish\u2014Chemotherapy response assay in vivo. Br. J. Haematol. 153, 786\u2013789. https:\/\/doi.org\/10.1111\/j.1365-2141.2011.08661.x (2011).","journal-title":"Br. J. Haematol."},{"key":"85141_CR18","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3324\/haematol.2014.110742","volume":"100","author":"VL Bentley","year":"2015","unstructured":"Bentley, V. L. et al. Focused chemical genomics using zebrafish xenotransplantation as a pre-clinical therapeutic platform for T-cell acute lymphoblastic leukemia. Haematologica 100, 70\u201376. https:\/\/doi.org\/10.3324\/haematol.2014.110742 (2015).","journal-title":"Haematologica"},{"key":"85141_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/s0145-305x(03)00103-4","volume":"28","author":"SH Lam","year":"2004","unstructured":"Lam, S. H., Chua, H. L., Gong, Z., Lam, T. J. & Sin, Y. M. Development and maturation of the immune system in zebrafish, Danio rerio: A gene expression profiling, in situ hybridization and immunological study. Dev. Comp. Immunol. 28, 9\u201328. https:\/\/doi.org\/10.1016\/s0145-305x(03)00103-4 (2004).","journal-title":"Dev. Comp. Immunol."},{"key":"85141_CR20","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/s1074-7613(04)00084-6","volume":"20","author":"NS Trede","year":"2004","unstructured":"Trede, N. S., Langenau, D. M., Traver, D., Look, A. T. & Zon, L. I. The use of zebrafish to understand immunity. Immunity 20, 367\u2013379. https:\/\/doi.org\/10.1016\/s1074-7613(04)00084-6 (2004).","journal-title":"Immunity"},{"key":"85141_CR21","doi-asserted-by":"publisher","first-page":"10358","DOI":"10.1038\/ncomms10358","volume":"7","author":"Q Tang","year":"2016","unstructured":"Tang, Q. et al. Imaging tumour cell heterogeneity following cell transplantation into optically clear immune-deficient zebrafish. Nat. Commun. 7, 10358. https:\/\/doi.org\/10.1038\/ncomms10358 (2016).","journal-title":"Nat. Commun."},{"key":"85141_CR22","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/path.4013","volume":"227","author":"S He","year":"2012","unstructured":"He, S. et al. Neutrophil-mediated experimental metastasis is enhanced by VEGFR inhibition in a zebrafish xenograft model. J. Pathol. 227, 431\u2013445. https:\/\/doi.org\/10.1002\/path.4013 (2012).","journal-title":"J. Pathol."},{"key":"85141_CR23","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1161\/ATVBAHA.111.226969","volume":"31","author":"O Pozzoli","year":"2011","unstructured":"Pozzoli, O. et al. Endothelial fate and angiogenic properties of human CD34+ progenitor cells in zebrafish. Arterioscler. Thromb. Vasc. Biol. 31, 1589\u20131597. https:\/\/doi.org\/10.1161\/ATVBAHA.111.226969 (2011).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"85141_CR24","doi-asserted-by":"publisher","unstructured":"Hamilton, N., Sabroe, I. & Renshaw, S. A. A method for transplantation of human HSCs into zebrafish, to replace humanised murine transplantation models. F1000Research 7, 594, https:\/\/doi.org\/10.12688\/f1000research.14507.2 (2018).","DOI":"10.12688\/f1000research.14507.2"},{"key":"85141_CR25","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1089\/scd.2015.0195","volume":"25","author":"FJ Staal","year":"2016","unstructured":"Staal, F. J., Spaink, H. P. & Fibbe, W. E. Visualizing human hematopoietic stem cell trafficking in vivo using a zebrafish xenograft model. Stem Cells Dev. 25, 360\u2013365. https:\/\/doi.org\/10.1089\/scd.2015.0195 (2016).","journal-title":"Stem Cells Dev."},{"key":"85141_CR26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13045-015-0126-4","volume":"8","author":"P Rasighaemi","year":"2015","unstructured":"Rasighaemi, P., Basheer, F., Liongue, C. & Ward, A. C. Zebrafish as a model for leukemia and other hematopoietic disorders. J. Hematol. Oncol. 8, 29. https:\/\/doi.org\/10.1186\/s13045-015-0126-4 (2015).","journal-title":"J. Hematol. Oncol."},{"key":"85141_CR27","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1371\/journal.pbio.0030254","volume":"3","author":"CE Eckfeldt","year":"2005","unstructured":"Eckfeldt, C. E. et al. Functional analysis of human hematopoietic stem cell gene expression using zebrafish. PLoS Biol. 3, e254. https:\/\/doi.org\/10.1371\/journal.pbio.0030254 (2005).","journal-title":"PLoS Biol."},{"key":"85141_CR28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrd1606","volume":"4","author":"LI Zon","year":"2005","unstructured":"Zon, L. I. & Peterson, R. T. In vivo drug discovery in the zebrafish. Nat. Rev. Drug Discov. 4, 35\u201344. https:\/\/doi.org\/10.1038\/nrd1606 (2005).","journal-title":"Nat. Rev. Drug Discov."},{"key":"85141_CR29","doi-asserted-by":"publisher","first-page":"5621","DOI":"10.1182\/blood-2011-12-398818","volume":"119","author":"S Ridges","year":"2012","unstructured":"Ridges, S. et al. Zebrafish screen identifies novel compound with selective toxicity against leukemia. Blood 119, 5621\u20135631. https:\/\/doi.org\/10.1182\/blood-2011-12-398818 (2012).","journal-title":"Blood"},{"key":"85141_CR30","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/978-3-319-30654-4_15","volume":"916","author":"NR Harrison","year":"2016","unstructured":"Harrison, N. R., Laroche, F. J., Gutierrez, A. & Feng, H. Zebrafish models of human leukemia: Technological advances and mechanistic insights. Adv. Exp. Med. Biol. 916, 335\u2013369. https:\/\/doi.org\/10.1007\/978-3-319-30654-4_15 (2016).","journal-title":"Adv. Exp. Med. Biol."},{"key":"85141_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.exphem.2016.09.012","volume":"45","author":"AP Deveau","year":"2017","unstructured":"Deveau, A. P., Bentley, V. L. & Berman, J. N. Using zebrafish models of leukemia to streamline drug screening and discovery. Exp. Hematol. 45, 1\u20139. https:\/\/doi.org\/10.1016\/j.exphem.2016.09.012 (2017).","journal-title":"Exp. Hematol."},{"key":"85141_CR32","doi-asserted-by":"publisher","first-page":"641475","DOI":"10.1155\/2015\/641475","volume":"2015","author":"JW Lu","year":"2015","unstructured":"Lu, J. W. et al. Zebrafish as a model for the study of human myeloid malignancies. Biomed. Res. Int. 2015, 641475. https:\/\/doi.org\/10.1155\/2015\/641475 (2015).","journal-title":"Biomed. Res. Int."},{"key":"85141_CR33","doi-asserted-by":"publisher","first-page":"e85439","DOI":"10.1371\/journal.pone.0085439","volume":"9","author":"B Zhang","year":"2014","unstructured":"Zhang, B. et al. Quantitative phenotyping-based in vivo chemical screening in a zebrafish model of leukemia stem cell xenotransplantation. PLoS ONE 9, e85439. https:\/\/doi.org\/10.1371\/journal.pone.0085439 (2014).","journal-title":"PLoS ONE"},{"key":"85141_CR34","doi-asserted-by":"publisher","first-page":"R163","DOI":"10.1530\/ERC-19-0437","volume":"27","author":"G Gaudenzi","year":"2020","unstructured":"Gaudenzi, G. et al. Fishing for neuroendocrine tumors. Endocr. Relat. Cancer 27, R163\u2013R176. https:\/\/doi.org\/10.1530\/ERC-19-0437 (2020).","journal-title":"Endocr. Relat. Cancer"},{"key":"85141_CR35","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/s12020-016-1048-9","volume":"57","author":"G Gaudenzi","year":"2017","unstructured":"Gaudenzi, G. et al. Patient-derived xenograft in zebrafish embryos: A new platform for translational research in neuroendocrine tumors. Endocrine 57, 214\u2013219. https:\/\/doi.org\/10.1007\/s12020-016-1048-9 (2017).","journal-title":"Endocrine"},{"key":"85141_CR36","doi-asserted-by":"publisher","first-page":"e304","DOI":"10.1038\/bcj.2015.25","volume":"5","author":"CC Coombs","year":"2015","unstructured":"Coombs, C. C., Tavakkoli, M. & Tallman, M. S. Acute promyelocytic leukemia: Where did we start, where are we now, and the future. Blood Cancer J. 5, e304. https:\/\/doi.org\/10.1038\/bcj.2015.25 (2015).","journal-title":"Blood Cancer J."},{"key":"85141_CR37","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1745-7254.2008.00771.x","volume":"29","author":"WY Au","year":"2008","unstructured":"Au, W. Y. & Kwong, Y. L. Arsenic trioxide: Safety issues and their management. Acta Pharmacol. Sin. 29, 296\u2013304. https:\/\/doi.org\/10.1111\/j.1745-7254.2008.00771.x (2008).","journal-title":"Acta Pharmacol. Sin."},{"key":"85141_CR38","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/s0065-230x(08)60765-4","volume":"74","author":"TS Lewis","year":"1998","unstructured":"Lewis, T. S., Shapiro, P. S. & Ahn, N. G. Signal transduction through MAP kinase cascades. Adv. Cancer Res. 74, 49\u2013139. https:\/\/doi.org\/10.1016\/s0065-230x(08)60765-4 (1998).","journal-title":"Adv. Cancer Res."},{"key":"85141_CR39","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1172\/JCI12807","volume":"108","author":"M Milella","year":"2001","unstructured":"Milella, M. et al. Therapeutic targeting of the MEK\/MAPK signal transduction module in acute myeloid leukemia. J. Clin. Investig. 108, 851\u2013859. https:\/\/doi.org\/10.1172\/JCI12807 (2001).","journal-title":"J. Clin. Investig."},{"key":"85141_CR40","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/leu.2013.342","volume":"28","author":"KR Kampen","year":"2014","unstructured":"Kampen, K. R. et al. Insights in dynamic kinome reprogramming as a consequence of MEK inhibition in MLL-rearranged AML. Leukemia 28, 589\u2013599. https:\/\/doi.org\/10.1038\/leu.2013.342 (2014).","journal-title":"Leukemia"},{"key":"85141_CR41","doi-asserted-by":"publisher","unstructured":"Eguchi, M., Minami, Y., Kuzume, A. & Chi, S. Mechanisms underlying resistance to FLT3 inhibitors in acute myeloid leukemia. Biomedicines 8, https:\/\/doi.org\/10.3390\/biomedicines8080245 (2020).","DOI":"10.3390\/biomedicines8080245"},{"key":"85141_CR42","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1182\/blood-2006-05-023804","volume":"109","author":"O Piloto","year":"2007","unstructured":"Piloto, O. et al. Prolonged exposure to FLT3 inhibitors leads to resistance via activation of parallel signaling pathways. Blood 109, 1643\u20131652. https:\/\/doi.org\/10.1182\/blood-2006-05-023804 (2007).","journal-title":"Blood"},{"key":"85141_CR43","doi-asserted-by":"publisher","first-page":"5120","DOI":"10.1038\/onc.2010.273","volume":"29","author":"E Weisberg","year":"2010","unstructured":"Weisberg, E., Sattler, M., Ray, A. & Griffin, J. D. Drug resistance in mutant FLT3-positive AML. Oncogene 29, 5120\u20135134. https:\/\/doi.org\/10.1038\/onc.2010.273 (2010).","journal-title":"Oncogene"},{"key":"85141_CR44","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1158\/0008-5472.CAN-15-1580","volume":"76","author":"W Zhang","year":"2016","unstructured":"Zhang, W. et al. The dual MEK\/FLT3 inhibitor E6201 exerts cytotoxic activity against acute myeloid leukemia cells harboring resistance-conferring FLT3 mutations. Can. Res. 76, 1528\u20131537. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-1580 (2016).","journal-title":"Can. Res."},{"key":"85141_CR45","doi-asserted-by":"publisher","first-page":"18630","DOI":"10.1038\/s41598-019-54901-9","volume":"9","author":"ML Morales","year":"2019","unstructured":"Morales, M. L. et al. MEK inhibition enhances the response to tyrosine kinase inhibitors in acute myeloid leukemia. Sci. Rep. 9, 18630. https:\/\/doi.org\/10.1038\/s41598-019-54901-9 (2019).","journal-title":"Sci. Rep."},{"key":"85141_CR46","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1158\/1078-0432.CCR-07-1388","volume":"14","author":"P Bertino","year":"2008","unstructured":"Bertino, P. et al. Imatinib mesylate enhances therapeutic effects of gemcitabine in human malignant mesothelioma xenografts. Clin. Cancer Res. 14, 541\u2013548. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-1388 (2008).","journal-title":"Clin. Cancer Res."},{"key":"85141_CR47","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1111\/j.1349-7006.2003.tb01393.x","volume":"94","author":"M Kito","year":"2003","unstructured":"Kito, M. et al. Antitumor effect of arsenic trioxide in murine xenograft model. Cancer Sci. 94, 1010\u20131014. https:\/\/doi.org\/10.1111\/j.1349-7006.2003.tb01393.x (2003).","journal-title":"Cancer Sci."},{"key":"85141_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12030567","author":"S Pascoal","year":"2020","unstructured":"Pascoal, S. et al. A preclinical embryonic zebrafish xenograft model to investigate CAR T cells in vivo. Cancers. https:\/\/doi.org\/10.3390\/cancers12030567 (2020).","journal-title":"Cancers."},{"key":"85141_CR49","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.trecan.2020.03.012","volume":"6","author":"J Xiao","year":"2020","unstructured":"Xiao, J., Glasgow, E. & Agarwal, S. Zebrafish xenografts for drug discovery and personalized medicine. Trends Cancer 6, 569\u2013579. https:\/\/doi.org\/10.1016\/j.trecan.2020.03.012 (2020).","journal-title":"Trends Cancer"},{"key":"85141_CR50","doi-asserted-by":"publisher","DOI":"10.3791\/59507","author":"L Wang","year":"2019","unstructured":"Wang, L. et al. Patient-derived heterogeneous xenograft model of pancreatic cancer using zebrafish larvae as hosts for comparative drug assessment. J. Vis. Exp. JoVE https:\/\/doi.org\/10.3791\/59507 (2019).","journal-title":"J. Vis. Exp. JoVE"},{"key":"85141_CR51","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/sj.onc.1203354","volume":"19","author":"F Hayakawa","year":"2000","unstructured":"Hayakawa, F. et al. Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines. Oncogene 19, 624\u2013631. https:\/\/doi.org\/10.1038\/sj.onc.1203354 (2000).","journal-title":"Oncogene"},{"key":"85141_CR52","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.223040","author":"V Rajan","year":"2019","unstructured":"Rajan, V. et al. Humanized zebrafish enhance human hematopoietic stem cell survival and promote acute myeloid leukemia clonal diversity. Haematologica https:\/\/doi.org\/10.3324\/haematol.2019.223040 (2019).","journal-title":"Haematologica"},{"key":"85141_CR53","doi-asserted-by":"publisher","first-page":"42438","DOI":"10.18632\/oncotarget.17124","volume":"8","author":"MS Butler","year":"2017","unstructured":"Butler, M. S. et al. Discovery and characterization of small molecules targeting the DNA-binding ETS domain of ERG in prostate cancer. Oncotarget 8, 42438\u201342454. https:\/\/doi.org\/10.18632\/oncotarget.17124 (2017).","journal-title":"Oncotarget"},{"key":"85141_CR54","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13046-017-0631-0","volume":"36","author":"JQ Wu","year":"2017","unstructured":"Wu, J. Q. et al. Patient-derived xenograft in zebrafish embryos: A new platform for translational research in gastric cancer. J. Exp. Clin. Cancer Res. CR 36, 160. https:\/\/doi.org\/10.1186\/s13046-017-0631-0 (2017).","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"85141_CR55","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1182\/bloodadvances.2018019448","volume":"2","author":"NT Rahman","year":"2018","unstructured":"Rahman, N. T. et al. MRTFA augments megakaryocyte maturation by enhancing the SRF regulatory axis. Blood Adv. 2, 2691\u20132703. https:\/\/doi.org\/10.1182\/bloodadvances.2018019448 (2018).","journal-title":"Blood Adv."},{"key":"85141_CR56","unstructured":"Westerfield, M. The Zebrafish Book : A Guide for the Laboratory Use of Zebrafish (Brachydanio rerio). (M. Westerfield, 1993)."},{"key":"85141_CR57","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/aja.1002030302","volume":"203","author":"CB Kimmel","year":"1995","unstructured":"Kimmel, C. B., Ballard, W. W., Kimmel, S. R., Ullmann, B. & Schilling, T. F. Stages of embryonic development of the zebrafish. Dev. Dyn. 203, 253\u2013310. https:\/\/doi.org\/10.1002\/aja.1002030302 (1995).","journal-title":"Dev. Dyn."},{"key":"85141_CR58","first-page":"510","volume":"8","author":"XS Zhao","year":"2009","unstructured":"Zhao, X. S., Song, P. L., Sun, B., Jiang, H. C. & Liu, T. F. Arsenic trioxide inhibits metastatic potential of mouse hepatoma H22 cells in vitro and in vivo. Hepatobiliary Pancreatic Dis Int. HBPD Int 8, 510\u2013517 (2009).","journal-title":"Hepatobiliary Pancreatic Dis Int. HBPD Int"},{"key":"85141_CR59","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s11307-012-0588-5","volume":"15","author":"LG Flores 2nd","year":"2013","unstructured":"Flores, L. G. 2nd. et al. Monitoring therapy with MEK inhibitor U0126 in a novel Wilms tumor model in Wt1 knockout Igf2 transgenic mice using 18F-FDG PET with dual-contrast enhanced CT and MRI: Early metabolic response without inhibition of tumor growth. Mol. Imag. Biol. 15, 175\u2013185. https:\/\/doi.org\/10.1007\/s11307-012-0588-5 (2013).","journal-title":"Mol. Imag. Biol."},{"key":"85141_CR60","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1158\/1535-7163.MCT-07-2032","volume":"7","author":"F Cano","year":"2008","unstructured":"Cano, F., Pannel, R., Follows, G. A. & Rabbitts, T. H. Preclinical modeling of cytosine arabinoside response in Mll-Enl translocator mouse leukemias. Mol. Cancer Ther. 7, 730\u2013735. https:\/\/doi.org\/10.1158\/1535-7163.MCT-07-2032 (2008).","journal-title":"Mol. Cancer Ther."},{"key":"85141_CR61","first-page":"362","volume":"30","author":"S Vadlamudi","year":"1970","unstructured":"Vadlamudi, S., Choudry, J. N., Waravdekar, V. S., Kline, I. & Goldin, A. Effect of combination treatment with 5-azacytidine and cytidine on the life-span and spleen and bone marrow cells of leukemic (L1210) and nonleukemic mice. Can. Res. 30, 362\u2013369 (1970).","journal-title":"Can. Res."},{"key":"85141_CR62","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/sj.leu.2402679","volume":"16","author":"J Hoepfl","year":"2002","unstructured":"Hoepfl, J. et al. Effects of imatinib on bone marrow engraftment in syngeneic mice. Leukemia 16, 1584\u20131588. https:\/\/doi.org\/10.1038\/sj.leu.2402679 (2002).","journal-title":"Leukemia"},{"key":"85141_CR63","doi-asserted-by":"publisher","first-page":"7369","DOI":"10.1073\/pnas.0402248101","volume":"101","author":"DM Langenau","year":"2004","unstructured":"Langenau, D. M. et al. In vivo tracking of T cell development, ablation, and engraftment in transgenic zebrafish. Proc. Natl. Acad. Sci. U.S.A. 101, 7369\u20137374. https:\/\/doi.org\/10.1073\/pnas.0402248101 (2004).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"85141_CR64","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/s0145-305x(98)00009-3","volume":"22","author":"NS Trede","year":"1998","unstructured":"Trede, N. S. & Zon, L. I. Development of T-cells during fish embryogenesis. Dev. Comp. Immunol. 22, 253\u2013263. https:\/\/doi.org\/10.1016\/s0145-305x(98)00009-3 (1998).","journal-title":"Dev. Comp. Immunol."},{"key":"85141_CR65","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1006\/dbio.1996.8446","volume":"182","author":"CE Willett","year":"1997","unstructured":"Willett, C. E., Zapata, A. G., Hopkins, N. & Steiner, L. A. Expression of zebrafish rag genes during early development identifies the thymus. Dev. Biol. 182, 331\u2013341. https:\/\/doi.org\/10.1006\/dbio.1996.8446 (1997).","journal-title":"Dev. Biol."},{"key":"85141_CR66","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/(SICI)1097-0177(199904)214:4<323::AID-AJA5>3.0.CO;2-3","volume":"214","author":"CE Willett","year":"1999","unstructured":"Willett, C. E., Cortes, A., Zuasti, A. & Zapata, A. G. Early hematopoiesis and developing lymphoid organs in the zebrafish. Dev. Dyn. 214, 323\u2013336. https:\/\/doi.org\/10.1002\/(SICI)1097-0177(199904)214:4%3c323::AID-AJA5%3e3.0.CO;2-3 (1999).","journal-title":"Dev. Dyn."},{"key":"85141_CR67","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/978-3-642-57276-0_15","volume":"251","author":"M Schorpp","year":"2000","unstructured":"Schorpp, M. et al. Genetic dissection of thymus development. Curr. Top. Microbiol. Immunol. 251, 119\u2013124. https:\/\/doi.org\/10.1007\/978-3-642-57276-0_15 (2000).","journal-title":"Curr. Top. Microbiol. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-85141-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-85141-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-85141-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T04:54:58Z","timestamp":1670043298000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-85141-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,11]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["85141"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-85141-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,11]]},"assertion":[{"value":"6 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5715"}}